How to Appease the Appetite of Psychotropic Drugs
J Clin Psychiatry 1998;59(10):500-501
© Copyright 2014 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Obesity is reaching epidemic proportions in the United States, and psychotropic drugs may be important factors as both causes and treatments for it. Beyond mere monitoring of weight, psychiatrists who understand the neuropharmacology of obesity may be able to exploit this information to create clever drug selections, switches, or combinations to mitigate or reverse psychotropic drug-induced weight gain. Here we will discuss some tips for applying the concepts of the psychopharmacologic mechanisms relevant to psychotropic drug-induced changes in body weight1 to the selection of antidepressants and antipsychotics that can be risk factors for obesity.